7 results
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Active malignancy ... @Clotmaster #Management ... Thromboembolism #Treatment #Hematology ... #Anticoagulation
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
the treatment of cancer-associated ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
algorithm for VTE in Malignancy ... thrombosis in cancer ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
hematological malignancy ... from germinal center ... normal germinal center ... classification #hematology ... #oncology #management
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Thrombophilia • Cancer ... Bloodman #VTE #anticoagulation ... #duration #management ... #DVT #hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
distal DVT (without cancer ... at 3 Months • Cancer ... therapy or until cancer ... Treatment #Algorithm #management ... #hematology #anticoagulation
Hemophagocytic Lymphohistiocytosis (HLH)

High mortality without prompt recognition and management. HLH is a critical diagnostic consideration in
recognition and management ... it is often a cancer ... Approach • Initial management ... trigger: Infections, malignancy ... #Hematology #HemeOnc